Berkeley Lab is part of a multi-laboratory working group that recently received DOE Office of Science funding under the Coronavirus Aid, Relief, and Economic Security (CARES) Act to conduct R&D to help improve the nation’s COVID-19 testing capabilities.
Three of our Biosciences Area researchers are helping to lead the Lab’s efforts. Adam Arkin, a senior faculty scientist in the Environmental Genomics and Systems Biology (EGSB) Division, is leading a team that is developing computational approaches to develop and optimize COVID-19 diagnostic tests. Blake Simmons, director of the Biological Systems and Engineering (BSE) Division, is leading a team to evaluate the performance of a prototype digital microfluidic platform to miniaturize the assay used to detect COVID-19. Finally, Paul Adams, director of the Molecular Biophysics and Integrated Bioimaging (MBIB) Division, is part of a team that is exploring structure-based protein design for diagnostics.
The research is among a wide range of COVID-19 related research projects underway at Berkeley Lab, which has capabilities and facilities that are being called into action to quickly assist in the national COVID-19 response.
Read more in the Berkeley Lab News Center.
